RecruitingNot ApplicableNCT07618364
The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease
Sponsor
Rinsada
Enrollment
33 participants
Start Date
Jan 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The central hypothesis is that inflammation contributes to dry eye and that rinsing the palpebral conjunctiva, bulbar conjunctiva, and fornices will reduce the inflammatory burden on the ocular surface.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Rinsada for people with dry eye, dry eye syndromes, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICERinsada
Irrigation via irrigating eyelid retractor
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07618364
Related Trials
Clinical Applications of Advanced Ophthalmic Imaging
NCT031353271 location
BL-RX01-TFSTAB-1402
NCT07790211
Long-term Effects of Acoltremon vs. Control in Dry Eye Disease
NCT07659626
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
NCT063601331 location
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency
NCT075023781 location